Category
page 1Drug safety

thalidomide
Thalidomide, sold under the brand names Contergan, Distaval and Thalomid among others, is an oral administered medication used to treat a number of cancers (e.g., multiple myeloma), graft-versus-host disease, and many skin disorders (e.g., complications of leprosy such as skin lesions). Thalidomide has been used to treat conditions associated with HIV: aphthous ulcers, HIV-associated wasting syndrome, diarrhea, and Kaposi's sarcoma, but increases in HIV viral load have been reported.
over-the-counter drug
medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may only be sold to consumers possessing a valid prescription
mefloquine
Mefloquine, sold under the brand name Lariam among others, is a medication used to prevent or treat malaria. When used for prevention it is typically started before potential exposure and continued for several weeks after potential exposure. It can be used to treat mild or moderate malaria but is not recommended for severe malaria. It is taken by mouth.
adverse drug reaction
unintended effect due to administration of one or more drugs
drug interaction
change in the action or side effects of a drug caused by another drug
shelf life
length of time that a commodity may be stored without becoming unfit for use or consumption
expiration date
previously determined date after which something should no longer be used
adverse effect
undesired harmful effect resulting from a medication or other medical intervention
pharmacovigilance
Pharmacovigilance (PV, or PhV), also known as drug safety, is the discipline within pharmaceutical science that addresses the identification, evaluation, and mitigation of adverse effects and other drug-related problems associated with pharmaceutical products.
topical steroid addiction
medical condition

polypharmacy
thumb|Polypharmacy is often defined as taking 5 or more medicines.
Polypharmacy (polypragmasia) is an umbrella term to describe the simultaneous use of multiple medicines by a patient for their conditions. The term polypharmacy is often defined as regularly taking five or more medicines but there is no standard definition and the term has also been used in the context of when a person is prescribed 2 or more medications at the same time. Polypharmacy may be the consequence of having multiple long-term conditions, also known as multimorbidity and is more common in the elderly. In some cases, an
regulation of therapeutic goods
regulation designed mainly to protect the health and safety of the population, aiming at ensuring the safety, quality, and efficacy of the therapeutic goods
drug allergy
human disease
Phocomelia due to thalidomide
medical condition
needle exchange programme
method of providing drug users with uninfected equipment
supervised injection site
medical facility
Chicago Tylenol murders
string of murders in Chicago in 1982 involving poisoned Tylenol medicine
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
Initiative to promote public health
vaccine adverse event
adverse event caused by vaccination
toxic cough syrup
mass poisonings since the 1990s
Common Technical Document
internationally agreed format for drug approvals
institutional review board
hospital or other institutional committees established to protect the welfare of research subjects
eosinophilia-myalgia syndrome
Human disease
Elixir sulfanilamide
Improperly prepared sulfanilamide medicine that caused mass poisoning in the US in 1937
serious adverse event
untoward medical occurrence in human medical trials that is sufficiently serious and meeting criteria such as resulting in death, life-threatening situation, inpatient hospitalization, disability or incapacity, birth defect, or permanent impairment
Investigational New Drug
United States Food and Drug Administration's Investigational New Drug (IND) program
Poly Implant Prothèse
company
Naranjo algorithm
Drug reaction questionnaire
EudraVigilance
EudraVigilance (European Union Drug Regulating Authorities Pharmacovigilance) is the European data processing network and management system for reporting and evaluation of suspected adverse reactions to medicines or devices which have received marketing authorisation or are actively being studied in clinical trials in the European Economic Area (EEA). The European Medicines Agency (EMA) operates the system on behalf of the European Union (EU) medicines regulatory network.
time temperature indicator
chemical indicator used for food safety and other applications
International Overdose Awareness Day
global event